Fusion polypeptide comprising polypeptide region that can be o-glycosylated
A fusion polypeptide and glycosylation technology, which is applied in fusion polypeptides, polypeptides containing positioning/targeting motifs, polypeptides containing affinity tags, etc., can solve problems such as protein denaturation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0124] Embodiment 1: the generation of fusion polypeptide
[0125] 1.1. Production of fusion polypeptides containing human growth hormone (hGH) as the target polypeptide
[0126] Fusion polypeptides IgD-hGH-His(DHDD-8His), IgD-hGH(DHDD), IgA-hGH(AHAA), IgD-hGH-IgA(DHAA) and IgA-hGH-IgD(AHDD) were generated (see figure 1 ; the underlined part of the IgD and IgA1 sequences is the part capable of performing O-glycosylation), wherein the IgD hinge IgA1 hinge Or a combination of IgD hinge and IgAl hinge fused to the target polypeptide (human growth hormone: hGH; SEQ ID NO: 3). The amino acid sequence of each moiety contained in the fusion polypeptide is summarized in Table 2 below.
[0127] 【Table 2】
[0128]
[0129] 1.1.1. IgD-hGH (DHDD)
[0130] Plasmid pAF-D1G1 (including Korean Patent No. 10-1868139B1 promoter)) into which is inserted the code '(N-terminus)-[BamHI restriction site-signal peptide (SEQ ID NO:4)-IgD hinge (IgDH1; SEQ ID NO:1)- Human growth hormone (hG...
Embodiment 2
[0186] Example 2: Pharmacokinetic properties (PK profile) test of fusion polypeptide (in vivo)
[0187] 2-1. Target protein: human growth hormone (hGH)
[0188] The fusion polypeptide IgD-hGH, IgD-hGH-His, IgA-hGH F3 (fraction 3 of Example 1.1.3), IgA-hGH F4 (fraction 4 of Example 1.1.3) prepared in Example 1.1 and IgA-hGH F5 (execution fraction 5 of Example 1.1.3) were subcutaneously administered to SD rats (Orientbio, 7 weeks old, about 300 g; n=3) at a dose of 2 mg / kg, and the pharmacokinetics were tested . Sampling was performed at 0, 0.5, 1, 2, 4, 6, 8, 24, 48 hours, and for comparison, hGH (Eutropin, LG Chem) was subcutaneously administered at a dose of 2 mg / kg in the same manner as above, and carry out testing.
[0189] After administration to SD rats as described above, the blood collected at the time point was centrifuged to obtain serum. ELISA was performed using the Human Growth Hormone Quantikine ELISA Kit (R&D Systems), and after confirmation of hGH and fusion...
PUM
Property | Measurement | Unit |
---|---|---|
molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com